![H. Brett Friedman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profiel
H.
Brett Friedman currently works as a Director at Cranius LLC.
Actieve functies van H. Brett Friedman
Bedrijven | Functie | Begin |
---|---|---|
Cranius LLC
![]() Cranius LLC Medical SpecialtiesHealth Technology Cranius LLC is a company based in Maryland that aims to invent and engineer technology to define the future of diagnostics and treatments for patients with chronic brain disease. The American company's flagship device, the Neuropass, is being developed to bypass the challenges presented by the blood-brain barrier, which has rendered traditional therapeutic treatments of brain disease ineffective. Cranius utilizes a novel pump design, refillable reservoir, MRI-lucent components, and wireless charging technology to enable long-term and direct medicine administration. The company was founded in May 2021 as a byproduct of the emerging field known as "neuroplastic and reconstructive surgery," through the vision, insight, and pioneering work of Dr. Chad Gordon. The CEO is Mike Maglin. | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Cranius LLC
![]() Cranius LLC Medical SpecialtiesHealth Technology Cranius LLC is a company based in Maryland that aims to invent and engineer technology to define the future of diagnostics and treatments for patients with chronic brain disease. The American company's flagship device, the Neuropass, is being developed to bypass the challenges presented by the blood-brain barrier, which has rendered traditional therapeutic treatments of brain disease ineffective. Cranius utilizes a novel pump design, refillable reservoir, MRI-lucent components, and wireless charging technology to enable long-term and direct medicine administration. The company was founded in May 2021 as a byproduct of the emerging field known as "neuroplastic and reconstructive surgery," through the vision, insight, and pioneering work of Dr. Chad Gordon. The CEO is Mike Maglin. | Health Technology |